Millennium Management’s Precision BioSciences DTIL Stock Holding History

Millennium Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$152K	Buy	+27,684	New	+$128K	﹤0.01%	5253
2025 Q2	–	Sell	-65,586	Closed	-$313K	–	5957
2025 Q1	$313K	Buy	+65,586	New	+$334K	﹤0.01%	5081
2024 Q1	–	Sell	-7,793	Closed	-$85.3K	–	6262
2023 Q4	$85.3K	Sell	7,793 -1,996	-20%	-$21.5K	﹤0.01%	5379
2023 Q3	$100K	Buy	9,789 +426	+5%	+$6.55K	﹤0.01%	5339
2023 Q2	$148K	Sell	9,363 -67,128	-88%	-$1.53M	﹤0.01%	5228
2023 Q1	$1.73M	Sell	76,491 -36,176	-32%	-$1.19M	﹤0.01%	3578
2022 Q4	$4.02M	Sell	112,667 -28,380	-20%	-$1.12M	﹤0.01%	2998
2022 Q3	$5.5M	Buy	141,047 +89,906	+176%	+$4.27M	﹤0.01%	2801
2022 Q2	$2.46M	Buy	51,141 +37,315	+270%	+$2.19M	﹤0.01%	3487
2022 Q1	$1.28M	Sell	13,826 -2,625	-16%	-$357K	﹤0.01%	4302
2021 Q4	$3.65M	Buy	16,451 +5,356	+48%	+$1.5M	﹤0.01%	3199
2021 Q3	$3.84M	Sell	11,095 -6,014	-35%	-$2.04M	﹤0.01%	3185
2021 Q2	$6.43M	Sell	17,109 -30	-0.2%	-$9.01K	﹤0.01%	2428
2021 Q1	$5.32M	Sell	17,139 -1,967	-10%	-$689K	﹤0.01%	2502
2020 Q4	$4.78M	Buy	19,106 +14,578	+322%	+$3.57M	﹤0.01%	2488
2020 Q3	$837	Sell	4,528 -18,461	-80%	-$3.67M	﹤0.01%	3253
2020 Q2	$5.75M	Buy	22,989 +17,523	+321%	+$3.84M	0.01%	1629
2020 Q1	$989K	Buy	+5,466	New	+$1.43M	﹤0.01%	2474
2019 Q4	–	Sell	-450	Closed	-$113K	–	4299
2019 Q3	$113K	Buy	+450	New	+$146K	﹤0.01%	3947
2019 Q2	–	Sell	-5,717	Closed	-$3.08M	–	4122
2019 Q1	$3.08M	Buy	+5,717	New	+$3.03M	﹤0.01%	2104

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management's DTIL Position: Q1 2026 in Review

Millennium Management opened a new position in Precision BioSciences (DTIL) in Q1 2026: 27,684 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #5253 among its holdings. This is a return to the name: Millennium Management previously reported a position in DTIL as recently as Q1 2025.

Millennium Management first reported a position in DTIL in Q1 2019 and has held it in 20 quarters since. The position peaked at $6.43M in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Millennium Management held 27,684 shares of Precision BioSciences worth $152K as of Q1 2026.
Precision BioSciences was a new Millennium Management position in Q1 2026.
Precision BioSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5253 holding.
Millennium Management first reported a position in Precision BioSciences in Q1 2019 and has held it in 20 quarters since.
Millennium Management's Precision BioSciences position peaked at $6.43M in Q2 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.